PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS. GenApp 2018, 2 (2), 51-56. https://doi.org/10.31383/ga.vol2iss2pp51-56.